Ekso Bionics Holdings Inc (EKSO)vsResMed Inc (RMD)
EKSO
Ekso Bionics Holdings Inc
$11.80
+0.08%
HEALTHCARE · Cap: $42.01M
RMD
ResMed Inc
$218.27
-0.60%
HEALTHCARE · Cap: $31.89B
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 44071% more annual revenue ($5.65B vs $12.80M). RMD leads profitability with a 27.0% profit margin vs -91.4%. RMD earns a higher WallStSmart Score of 65/100 (C+).
EKSO
Avoid17
out of 100
Grade: F
RMD
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for EKSO.
Margin of Safety
-24.1%
Fair Value
$209.29
Current Price
$218.27
$8.98 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Strong operational efficiency at 30.9%
Safe zone — low bankruptcy risk
Every $100 of equity generates 23 in profit
Keeps 27 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Generating 1.6B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -162.1% — below average capital efficiency
Revenue declined 38.3%
2.4% earnings growth
Comparative Analysis Report
WallStSmart ResearchBull Case : EKSO
EKSO has a balanced fundamental profile.
Bull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.0% and operating margin at 30.9%. PEG of 1.33 suggests the stock is reasonably priced for its growth.
Bear Case : EKSO
The primary concerns for EKSO are EPS Growth, Market Cap, Return on Equity.
Bear Case : RMD
The primary concerns for RMD are EPS Growth.
Key Dynamics to Monitor
EKSO profiles as a turnaround stock while RMD is a mature play — different risk/reward profiles.
EKSO carries more volatility with a beta of 0.78 — expect wider price swings.
RMD is growing revenue faster at 8.6% — sustainability is the question.
RMD generates stronger free cash flow (1.6B), providing more financial flexibility.
Bottom Line
RMD scores higher overall (65/100 vs 17/100), backed by strong 27.0% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ekso Bionics Holdings Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company is headquartered in Richmond, California.
Visit Website →ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?